Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 YearsNarjust Duma, Alex A. Adjei, Jesus Vera Aguilera et al.|Journal of Oncology Practice|2017Cited by 447
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L. Haddox, Suzanne George, Jia‐Ren Lin et al.|Clinical Cancer Research|2024Cited by 35
ETCTN 10563: A phase I study of peposertib and liposomal doxorubicin for advanced or metastatic leiomyosarcoma and other sarcomas.Candace L. Haddox, Suzanne George, Karla V. Ballman et al.|Journal of Clinical Oncology|2025Cited by 1
Data from Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L. Haddox, Suzanne George, Michael J. Nathenson et al.|Unknown|2024Cited by 1
Supplementary Figure 1 from Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L. Haddox, Suzanne George, Michael J. Nathenson et al.|Unknown|2024Cited by 1